OtherArticle
RISK ASSESSMENT FOR DRUG-DRUG INTERACTION CAUSED BY METABOLISM-BASED INHIBITION OF CYP3A USING AUTOMATED IN VITRO ASSAY SYSTEMS AND ITS APPLICATION IN THE EARLY DRUG DISCOVERY PROCESS
Akiko Watanabe, Koichi Nakamura, Noriko Okudaira, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition March 28, 2007, DOI: https://doi.org/10.1124/dmd.107.015016
Akiko Watanabe
Koichi Nakamura
Noriko Okudaira
Osamu Okazaki
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
RISK ASSESSMENT FOR DRUG-DRUG INTERACTION CAUSED BY METABOLISM-BASED INHIBITION OF CYP3A USING AUTOMATED IN VITRO ASSAY SYSTEMS AND ITS APPLICATION IN THE EARLY DRUG DISCOVERY PROCESS
Akiko Watanabe, Koichi Nakamura, Noriko Okudaira, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition March 28, 2007, DOI: https://doi.org/10.1124/dmd.107.015016
OtherArticle
RISK ASSESSMENT FOR DRUG-DRUG INTERACTION CAUSED BY METABOLISM-BASED INHIBITION OF CYP3A USING AUTOMATED IN VITRO ASSAY SYSTEMS AND ITS APPLICATION IN THE EARLY DRUG DISCOVERY PROCESS
Akiko Watanabe, Koichi Nakamura, Noriko Okudaira, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition March 28, 2007, DOI: https://doi.org/10.1124/dmd.107.015016
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement